are glp-1 drugs covered by medicare CMS Issues Coverage Guidance on Anti-Obesity Medicare to cover GLP-1 weight

doi: 10.1161/STROKEAHA.121.037775

In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)

Key References Blher M, Rosenstock J, Hoefler J, et al

Systemically injected liraglutide (Vallf et al., 2016) and exenatide (Egecioglu, Steensland, et al., 2013) attenuate alcoholinduced accumbal dopamine release, and exenatide injection into the NTS also attenuates this response as well (Vallf, Vestlund, et al., 2019)